New distributor alliances in Finland and Turkey accelerate global growth, providing greater reach and customer convenience worldwide
Peli BioThermal, the global name in temperature controlled packaging, announces additional distributor partnerships expanding the company’s growing global network. Peli BioThermal continues to expand its worldwide distributor base providing comprehensive customer convenience with the announcement of commercial collaborations with Sharkmed Oy in Finland and Corena Pharmaceutical Wholesaler located in Turkey.
Paul Terry, Director of Sales EMEA at Peli BioThermal, said: “We are delighted to be working with our new distributors who are operating in these key European locations. These additions further enhance Peli BioThermal’s growing global footprint, providing customers greater access to our full portfolio of high-performing products, including our deep frozen product range, which was recently expanded to support the ongoing response to the global pandemic.”
Founded in 2000, Sharkmed Oy specialises in supplying essential equipment to Emergency Medical Services, particularly Tactical Combat Casualty Care, alongside providing training in personal and fire safety. Based in Hyvinkaa, southern Finland, the company is also a long established distributor of high-performing cases provided by Peli BioThermal’s corporate parent, Peli Products.
Established in 1998 with its own robust service network, Corena Pharmaceutical Wholesaler supplies to 86 countries on six continents. The company is based in Turkey’s capital Ankara and specialises in the provision of pharmaceuticals and medical supplies internationally.
For more information about Peli BioThermal’s global network go to https://pelibiothermal.com/about-us/global-network or visit www.pelibiothermal.com to learn more about the wide range of Peli BioThermal products and offerings.
Peli BioThermal is a division of Peli Products, S.L.U., which is the European arm of Pelican Products, Inc., which is a portfolio company of Behrman Capital, a private equity investment firm based in New York and San Francisco.